Stents for palliation of obstructive metastatic colon cancer - Impact on management and chemotherapy administration

被引:97
作者
Karoui, Mehdi [1 ]
Charachon, Antoine [1 ]
Delbaldo, Catherine [1 ]
Loriau, Jerome [1 ]
Laurent, Alexis [1 ]
Sobhani, Iradj [1 ]
Van Nhieu, Jeanne Tran [1 ]
Delchier, Jean Charles [1 ]
Fagniez, Pierre-Louis [1 ]
Piedbois, Pascal [1 ]
Cherqui, Daniel [1 ]
机构
[1] Hop Henri Mondor, Serv Chirurg Digest, F-94010 Creteil, France
关键词
D O I
10.1001/archsurg.142.7.619
中图分类号
R61 [外科手术学];
学科分类号
摘要
Hypothesis: The more rapid and less complicated recovery after palliative stent insertion compared with surgery may theoretically facilitate the early administration of chemotherapy. Design: A retrospective study. Setting: University tertiary care referral center. Patients: From January 1, 1996, to September 15, 2005, 58 patients with obstructing colon cancer and nonresectable synchronous metastases were treated with self-expanding colonic metallic stent (SEMS) (n = 31) or surgery (n = 27). Main Outcome Measures: Comparison of the use of SEMS and emergency surgery as palliative measures to treat obstructing colon cancer with special reference to time to chemotherapy administration and survival. Results: Mortality and morbidity were comparable between the 2 groups. Median hospital stay was shorter after SEMS insertion than after surgery (median, 8.0 vs 13.5 days, respectively; P < .01). Incidence of stoma creation was lower in patients treated with SEMS than in patients treated with surgery (6% vs 37%, respectively; P = .02). The median time to chemotherapy administration was shorter after SEMS insertion than after surgery (14.0 vs 28.5 days, respectively; P = .002). Three patients with SEMS and 0 patients in the surgical group underwent a curative colonic and hepatic resection after downstaging by chemotherapy (P = .27). Two patients (6%) with SEMS and undergoing chemotherapy had a tumor perforation requiring emergency surgery. There was no difference in survival between the 2 groups (median survival, 13.7 months for SEMS vs 11.4 months for surgery; P = .19). Conclusions: Insertion of SEMS should be the first step to treat obstructing colon cancer with nonresectable synchronous metastases because it allows chemotherapy to be administered earlier, may increase the resectability rate of metastases, and favorably impacts survival. The risk of tumor perforation while receiving chemotherapy requires attention.
引用
收藏
页码:619 / 623
页数:5
相关论文
共 20 条
[1]  
Bhardwaj R, 2003, Colorectal Dis, V5, P518, DOI 10.1046/j.1463-1318.2003.00519.x
[2]   Acute colonic obstruction: Clinical aspects and cost-effectiveness of preoperative and palliative treatment with self-expanding metallic stents - A preliminary report [J].
Binkert, CA ;
Ledermann, H ;
Jost, R ;
Saurenmann, P ;
Decurtins, M ;
Zollikofer, CL .
RADIOLOGY, 1998, 206 (01) :199-204
[3]   Malignant colorectal obstruction treated by means of self-expanding metallic stents:: Effectiveness before surgery and in palliation [J].
Camúñez, F ;
Echenagusia, A ;
Simó, G ;
Turégano, F ;
Vázquez, J ;
Barreiro-Meiro, I .
RADIOLOGY, 2000, 216 (02) :492-497
[4]   Stents or open operation for palliation of colorectal cancer: A retrospective, cohort study of perioperative outcome and long-term survival [J].
Carne, PWG ;
Frye, JNR ;
Robertson, GM ;
Frizelle, FA .
DISEASES OF THE COLON & RECTUM, 2004, 47 (09) :1455-1461
[5]   Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer [J].
de Gramont, A ;
Figer, A ;
Seymour, M ;
Homerin, M ;
Hmissi, A ;
Cassidy, J ;
Boni, C ;
Cortes-Funes, H ;
Cervantes, A ;
Freyer, G ;
Papamichael, D ;
Le Bail, N ;
Louvet, C ;
Hendler, D ;
de Braud, F ;
Wilson, C ;
Morvan, F ;
Bonetti, A .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :2938-2947
[6]   Acute colorectal obstruction:: Stent placement for palliative treatment -: Results of a multicenter study [J].
De Gregorio, MA ;
Mainar, A ;
Tejero, E ;
Tobío, R ;
Alfonso, E ;
Pinto, I ;
Fernández, R ;
Herrera, M ;
Fernández, JA .
RADIOLOGY, 1998, 209 (01) :117-120
[7]   Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial [J].
Douillard, JY ;
Cunningham, D ;
Roth, AD ;
Navarro, M ;
James, RD ;
Karasek, P ;
Jandik, P ;
Iveson, T ;
Carmichael, J ;
Alakl, M ;
Gruia, G ;
Awad, L ;
Rougier, P .
LANCET, 2000, 355 (9209) :1041-1047
[8]   Current practices in left-sided colonic emergencies - A survey of US gastrointestinal surgeons [J].
Goyal, A ;
Schein, M .
DIGESTIVE SURGERY, 2001, 18 (05) :399-402
[9]   One-stage resection and anastomosis for acute obstruction of the left colon [J].
Hsu, TC .
DISEASES OF THE COLON & RECTUM, 1998, 41 (01) :28-32
[10]   Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].
Hurwitz, H ;
Fehrenbacher, L ;
Novotny, W ;
Cartwright, T ;
Hainsworth, J ;
Heim, W ;
Berlin, J ;
Baron, A ;
Griffing, S ;
Holmgren, E ;
Ferrara, N ;
Fyfe, G ;
Rogers, B ;
Ross, R ;
Kabbinavar, F .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342